Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link and the Revision: v3.3.2 entry have been removed. These changes do not affect the study information or page functionality.
    Difference
    0.1%
    Check dated 2025-12-21T21:09:38.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2; no substantive changes to trial details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T05:40:36.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The Publications section was updated: a sentence about voluntarily provided publications (revision 3.3.1) was added, and the previous sentence about study results (revision 3.2.0) was removed.
    Difference
    0.1%
    Check dated 2025-11-23T08:11:16.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Removal of the government funding status banner. This does not change the study details, eligibility criteria, or enrollment information shown on the page.
    Difference
    0.3%
    Check dated 2025-11-16T06:05:46.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    No significant changes detected in the study record NCT04131543; the screenshots show the same study details with minor formatting changes and potentially updated timestamps. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-02T00:36:30.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    Key update: page now warns about potential delays due to funding lapses and confirms the NIH Clinical Center is open, plus a version upgrade to v3.2.0.
    Difference
    2%
    Check dated 2025-10-04T11:32:03.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.